Clive Spiegler

Princeton, NJ United States

President and Disease Area Lead, Global Commercialization - Immunology

Medical / Health Care / Pharmaceuticals

Clive Spiegler serves as Senior Director for New Product Planning at the UK branch of Belgian-headquartered biopharmaceutical company UCB, S.A. His successful career extends back 18 years and includes a number of shared patents in the U.S. and Europe, and leadership roles in both product development and marketing for such innovative treatments as Humira, Kaletra, and Cimzia, a treatment for rheumatoid arthritis and Crohn’s disease. Clive Spiegler began his education in chemistry at the University of Surrey in his native England. In his third year of study, Clive Spiegler spent six months working for Alcon, Inc. in Kaysersberg, France, followed by an additional six months working in